Diatech Pharmacogenetics Overview

  • Founded
  • 1996

Founded
  • Status
  • Private

  • Employees
  • 60

Employees
  • Latest Deal Type
  • PE Growth

  • (Announced)
  • Financing Rounds
  • 2

  • Investments
  • 1

Diatech Pharmacogenetics General Information

Description

Developer of pharmacogenetics tests intended to identify gene mutations and genetic differences that are targets of personalized cancer therapies. The company offers services catering to the development, production and commercialization of molecular diagnostic tests for solid tumors, blood cancer and other infectious diseases, guiding diagnostic operators throughout the processes of sample extraction, quality control, molecular assay bioinformatic analysis and report, helping increase the effectiveness of cancer medicine through personalized diagnosis and treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
  • Ignazio Silone, 1/B
  • 60035 Jesi(Ancona)
  • Italy
+39 0731 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diatech Pharmacogenetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Diatech Pharmacogenetics‘s full profile, request access.

Request a free trial

Diatech Pharmacogenetics Executive Team (6)

Name Title Board Seat Contact Info
Oliva Alberti Chief Executive Officer
Fabio Biondi Founder, Co-Owner & President
Vincenzo Ciccone Chief Financial Officer
Maura Menghi Scientific Director
Gianmarco Musciano Technical Manager
You’re viewing 5 of 6 executive team members. Get the full list »

Diatech Pharmacogenetics Board Members (2)

Name Representing Role Since
0000000 0000000 Diatech Pharmacogenetics Member of the Board of Statutory Auditors 000 0000
00000000 000000000 Diatech Pharmacogenetics Board Member 000 0000
To view Diatech Pharmacogenetics’s complete board members history, request access »

Diatech Pharmacogenetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diatech Pharmacogenetics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Diatech Pharmacogenetics‘s full profile, request access.

Request a free trial

Diatech Pharmacogenetics Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 07-Feb-2011 000000000 IT Consulting and Outsourcing 00000 000
To view Diatech Pharmacogenetics’s complete investments history, request access »